Developing a Radiopharmaceutical Clinical Operations Strategy

• Reducing transit times whilst also ensuring regulatory adherence
• Reviewing the current regulatory and safety protocols – what is currently unclear?
• Investigating strategies to mitigate supply chain disruptions for isotopes with short half-lives

Speakers:

Lauren Creeden

Head of Clinical CMC Execution

Clarity